Evidence mapPaperPMID 41765972Full record

ArticleBMC public health2026

Prevalence, patterns, and associated factors of psychoactive substance use among people living with HIV in Lomé, Togo : a cross-sectional study.

Issifou Yaya, Panawé Kassang, Kokou Messanh Agbémélé Soedje, Koulté Hategou, Gountaanthe Logte Sanwogou, Akouda Akessiwe Patassi, Majesté Wateba Ihou, Bayaki Saka

Abstract read
In one paragraph

Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Issifou YayaCHU SO Lomé, Unité de Recherche en Santé des Populations (URESAP), Lomé, Togo.
Panawé KassangDermatology-Venerology Department, Centre Hospitalier Universitaire - Sylvanus Olympio (CHU-SO), Lomé, Togo. panawekassang@gmail.com.
Kokou Messanh Agbémélé SoedjePsychiatry Department, Centre Hospitalier Universitaire -Sylvanus Olympio (CHU-SO), Lomé, Togo.
Koulté HategouDermatology-Venerology Department, Centre Hospitalier Universitaire - Sylvanus Olympio (CHU-SO), Lomé, Togo.
Gountaanthe Logte SanwogouMinstry of Health and Public Hyygiene, Tchaoudjo Health District, Sokodé, Togo.
Akouda Akessiwe PatassiTropical and Infectious Disease Departement, Centre Hospitalier Universitaire -Sylvanus Olympio (CHU-SO), Lomé, Togo.
Majesté Wateba IhouTropical and Infectious Disease Departement, Centre Hospitalier Universitaire -Sylvanus Olympio (CHU-SO), Lomé, Togo.
Bayaki SakaDermatology-Venerology Department, Centre Hospitalier Universitaire - Sylvanus Olympio (CHU-SO), Lomé, Togo.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPsychoactive substance (PAS) use among people living with HIV (PLHIV) can adversely affect treatment adherence, disease progression, and mental health. Despite growing concern, there is limited data on the prevalence and correlates of substance use in this population in Togo. This study aimed to assess the prevalence, patterns, and associated factors of PAS use among PLHIV in Lomé.

methodsA cross-sectional survey was conducted between August and October 2023 among PLHIV attending HIV clinic of the infectious and tropical diseases department of the CHU Sylvanus Olympio in Lomé. Data were collected using a structured, pre-tested questionnaire administered through face-to-face interviews. Information was gathered on sociodemographic characteristics, ART adherence, and use of PAS (alcohol, tobacco, cannabis, others) in the past 12 months. Using STATA version 15.1, multivariate logistic regression analysis was used to determine factors associated with substance use.

resultsA total of 510 PLHIV were included in this study, of which 71.6% were women. Their average age was 48.0 ± 9.5 years. The prevalence of PAS use was 38.4% (95% CI: 34.3–42.7%). In the multivariable analysis, age between 40 and 49 years (aOR = 0.57; 95% CI:0.33–0.98; p = 0.043); the female sex (aOR = 0.36; 95% CI:0.23 ;0.56; p < 0.001); secondary or higher level of education (aOR = 0.63; 95% CI:0.41–0.98; p = 0.041); Christianity (aOR = 0.44; 95% CI:0.22–0.88; p = 0.020) or Islam religion (aOR = 0.17; 95% CI:0.04–0.44; p < 0.001); adherence to ARV treatment (aOR = 0.49; 95% CI:0.29–0.82; p = 0.008) and being sexually active (aOR = 1.69; 95% CI:1.12–2.55; p = 0.012) were the factors associated with the consumption of any PAS.

conclusionThe high prevalence of psychoactive substance use among PLHIV in Lomé calls for urgent policy and programmatic action. Routine screening, counseling, and integrated interventions should be prioritized to address both substance use and HIV care outcomes.

Indexed as

HIV InfectionsPsychotropic DrugsSubstance-Related DisordersAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrevalenceRisk FactorsSurveys and QuestionnairesTogoPsychotropic DrugsPLHIVPsychoactive substanceTogo

Identifiers

PMID41765972
PMCPMC13059273

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.